This also depends on how long it will take till the ex date, i.e how much dilution Solomon will put us through before they are distributed (there might also be dilution between the two ex dates).
There are other unknowns as well; the 5.2MM shares for ECAB (that might be renegotiated) isn't issued yet I believe (and 400k TRW-shares will go to ECAB anyways).
There has been a lot of back and forth with the collateral shares, but the last information (the response to Finansavisen) was that they are NOT entitled to any dividend (earlier they had to return the dividend upon repayment of the collateral loans).
Currently we have 42.9MM shares.
Best case; no more dilution, collateral shares does not get dividend (or get from the remaining 18.3% and have to return later), and the ECAB-note is renegotiated into cash settlement also without the 400k TRW-shares being giving. That gives 18.3M TRW-shares between 42.9-8.4=34.5MM SIAF-shares, i.e 0,53TRW/SIAF in dividend.
Realistic case? Some more dilution, collateral shares does not get dividend (according to the last information we have), 5.2MM for ECAB and 400k TRW-shares. That gives 17.9MM TRW-shares between 42.9-8.4+5.2+dilution=42MM???, i.e 0.42TRW/SIAF in dividend
Do we know that the collateral shares are included in the OS of common shares btw? Also, there seems to be some fault in the 10-Q; in the 10-K it states that as of December 31st there were 5.7MM shares for TFA&B (page 27) and 2.7MM shares for third parties. I.e a totalt of 8.4MM shares. In the 10-Q they refer to 4.8MM shares being unchanged from December 31st
